1. Home
  2. IRWD vs CBAN Comparison

IRWD vs CBAN Comparison

Compare IRWD & CBAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRWD
  • CBAN
  • Stock Information
  • Founded
  • IRWD 1998
  • CBAN 1975
  • Country
  • IRWD United States
  • CBAN United States
  • Employees
  • IRWD N/A
  • CBAN N/A
  • Industry
  • IRWD Biotechnology: Pharmaceutical Preparations
  • CBAN Major Banks
  • Sector
  • IRWD Health Care
  • CBAN Finance
  • Exchange
  • IRWD Nasdaq
  • CBAN Nasdaq
  • Market Cap
  • IRWD 251.8M
  • CBAN 300.7M
  • IPO Year
  • IRWD 2010
  • CBAN 1998
  • Fundamental
  • Price
  • IRWD $1.76
  • CBAN $16.58
  • Analyst Decision
  • IRWD Buy
  • CBAN
  • Analyst Count
  • IRWD 5
  • CBAN 0
  • Target Price
  • IRWD $4.94
  • CBAN N/A
  • AVG Volume (30 Days)
  • IRWD 1.2M
  • CBAN 44.7K
  • Earning Date
  • IRWD 11-04-2025
  • CBAN 10-22-2025
  • Dividend Yield
  • IRWD N/A
  • CBAN 2.75%
  • EPS Growth
  • IRWD N/A
  • CBAN 26.78
  • EPS
  • IRWD N/A
  • CBAN 1.59
  • Revenue
  • IRWD $308,519,000.00
  • CBAN $122,550,000.00
  • Revenue This Year
  • IRWD N/A
  • CBAN $21.97
  • Revenue Next Year
  • IRWD N/A
  • CBAN $27.53
  • P/E Ratio
  • IRWD N/A
  • CBAN $10.50
  • Revenue Growth
  • IRWD N/A
  • CBAN 12.48
  • 52 Week Low
  • IRWD $0.53
  • CBAN $13.99
  • 52 Week High
  • IRWD $5.13
  • CBAN $18.49
  • Technical
  • Relative Strength Index (RSI)
  • IRWD 63.49
  • CBAN 47.95
  • Support Level
  • IRWD $1.43
  • CBAN $16.29
  • Resistance Level
  • IRWD $1.71
  • CBAN $16.77
  • Average True Range (ATR)
  • IRWD 0.13
  • CBAN 0.44
  • MACD
  • IRWD 0.01
  • CBAN 0.02
  • Stochastic Oscillator
  • IRWD 66.04
  • CBAN 54.15

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.

About CBAN Colony Bankcorp Inc.

Colony Bankcorp Inc is a bank holding company. The bank provides a broad range of banking services to its retail and commercial customers. Its product line includes loans to small and medium-sized businesses, residential and commercial construction and land development loans, commercial real estate loans, agri-business and production loans, residential mortgage loans, consumer loans, and a variety of demand, savings, and time deposit products. The company's segments include the Banking Division, Retail Mortgage Division and small business specialty lending divisions. It generates maximum revenue from the Banking Division.

Share on Social Networks: